Clinical trials
Tuberculosis, Meningeal trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 6 |
| Recruiting | 5 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oxford University Clinical Research Unit, Vietnam | 4 |
| Universitas Padjadjaran | 4 |
| Beijing Chest Hospital | 3 |
| ANRS, Emerging Infectious Diseases | 2 |
| All India Institute of Medical Sciences | 2 |
| BioVersys AG | 1 |
| Chiang Mai University | 1 |
| David Boulware | 1 |
| Huashan Hospital | 1 |
| Hui Bu | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis, Meningeal | 30 |
| Tuberculosis | 8 |
| Meningitis | 4 |
| Chemical and Drug Induced Liver Injury | 2 |
| Latent Tuberculosis | 2 |
| AIDS-Related Opportunistic Infections | 1 |
| Acquired Immunodeficiency Syndrome | 1 |
| Arachnoiditis | 1 |
| Central Nervous System Diseases | 1 |
| Disease | 1 |
Trials
Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.